222 related articles for article (PubMed ID: 32401669)
21. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma.
Shaikh F; Chan AC; Awan O; Jerath N; Reddy C; Khan SA; Graham MM
Cureus; 2015 Sep; 7(9):e319. PubMed ID: 26487995
[TBL] [Abstract][Full Text] [Related]
22. A case report of secondary neurolymphomatosis showing selective nerve infiltration and massive lumbar plexus enlargement.
Hamaguchi M; Kokubun N; Matsuda H; Onuma H; Aoki R; Takahashi W; Mitani K; Suzuki K
BMC Neurol; 2021 Jul; 21(1):296. PubMed ID: 34311723
[TBL] [Abstract][Full Text] [Related]
23. Lumbosacral Plexus Neurolymphomatosis: A Typical 18FDG PET/CT Pattern to Recognize.
Bordeau K; Eberlé MC; Fabbro M; Fersing C; Deshayes E
Clin Nucl Med; 2022 Apr; 47(4):352-353. PubMed ID: 34739401
[TBL] [Abstract][Full Text] [Related]
24. Primary peripheral nerve lymphoma: a case report and literature review.
Wu D; Liu H; Hao L; Han X; Wang S; Xiang Y; Yu S; Wang Y
Neurol Sci; 2024 Apr; 45(4):1447-1454. PubMed ID: 37991640
[TBL] [Abstract][Full Text] [Related]
25. Primary cauda equina lymphoma confirmed by autopsy: A case report.
Ishizawa K; Komori T; Shimazaki R; Nakata Y; Tamaru JI; Sasaki A; Takahashi K
Neuropathology; 2024 Apr; 44(2):147-153. PubMed ID: 37640533
[TBL] [Abstract][Full Text] [Related]
26. Neurolymphomatosis as an Initial Presentation of Non Hodgkins Lymphoma: A Case Report.
Rohatgi S; Nirhale S; Rao P; Naphade P; Khan F
Neurol India; 2023; 71(5):991-993. PubMed ID: 37929441
[TBL] [Abstract][Full Text] [Related]
27. [A case of neurolymphomatosis: peripheral neuropathy induced by diffuse large B-cell lymphoma without any abnormal accumulation observed on early positron emission tomography-computed tomography].
Ebihara Y; Ishii N; Akizuki K; Taniguchi A; Mochizuki H; Inatsu A; Shiomi K; Nagamachi S; Nakazato M
Brain Nerve; 2015 Feb; 67(2):219-23. PubMed ID: 25681368
[TBL] [Abstract][Full Text] [Related]
28. (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.
Canh NX; Tan NV; Tung TT; Son NT; Maurea S
Asia Ocean J Nucl Med Biol; 2014; 2(1):57-64. PubMed ID: 27408859
[TBL] [Abstract][Full Text] [Related]
29. Clinical manifestations of, diagnostic approach to, and treatment of neurolymphomatosis in the rituximab era.
Khurana A; Novo M; Nowakowski GS; Ristow KM; Spinner RJ; Hunt CH; King RL; Lachance DH; Habermann TM; Micallef IN; Johnston PB
Blood Adv; 2021 Mar; 5(5):1379-1387. PubMed ID: 33661298
[TBL] [Abstract][Full Text] [Related]
30. Primary Central Nervous System Lymphoma With Diffuse Neurolymphomatosis Involving Multiple Cranial and Spinal Nerve Roots.
Singh SS; Mittal BR; Kumar R; Singh H; Balaini N; Goyal M
Clin Nucl Med; 2020 Jun; 45(6):e285-e287. PubMed ID: 32332304
[TBL] [Abstract][Full Text] [Related]
31. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT.
Lin M; Kilanowska J; Taper J; Chu J
Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824
[TBL] [Abstract][Full Text] [Related]
32. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes.
Jeong J; Kim SW; Sung DH
J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033
[TBL] [Abstract][Full Text] [Related]
33. Isolated primary neurolymphomatosis with cranial multineuritis: a case presentation.
Sheng S; Sharma R; Samant R; Yuan J; Nalleballe K; Kapoor N
Neurol Sci; 2021 Mar; 42(3):1223-1226. PubMed ID: 33040194
[TBL] [Abstract][Full Text] [Related]
34. 18F-FDG PET/CT diagnosis of vagus nerve neurolymphomatosis.
Tsang HH; Lee EY; Anthony MP; Khong PL
Clin Nucl Med; 2012 Sep; 37(9):897-8. PubMed ID: 22889783
[TBL] [Abstract][Full Text] [Related]
35. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis.
Kanter P; Zeidman A; Streifler J; Marmelstein V; Even-Sapir E; Metser U; Stein GY; Cohen AM
Eur J Haematol; 2005 Jan; 74(1):66-9. PubMed ID: 15613109
[TBL] [Abstract][Full Text] [Related]
36. [Neurolymphomatosis due to enteropathy-associated T-cell lymphoma clinically diagnosed by FDG-PET/CT and subsequently confirmed by autopsy].
Uematsu N; Sumi M; Kaiume H; Takeda W; Kirihara T; Ueki T; Hiroshima Y; Ueno M; Ichikawa N; Watanabe M; Kobayashi H
Rinsho Ketsueki; 2018; 59(1):69-74. PubMed ID: 29415941
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic utility of FDG-PET in neurolymphomatosis: report of five cases.
Kinoshita H; Yamakado H; Kitano T; Kitamura A; Yamashita H; Miyamoto M; Hitomi T; Okada T; Nakamoto Y; Sawamoto N; Takaori-Kondo A; Takahashi R
J Neurol; 2016 Sep; 263(9):1719-26. PubMed ID: 27286845
[TBL] [Abstract][Full Text] [Related]
38. Fluorothymidine PET/CT in neurolymphomatosis.
Biswal CK; Mittal BR; Shukla J; Vatsa R; Bhattacharya A; Prabhakar S
Clin Nucl Med; 2015 May; 40(5):e290-2. PubMed ID: 25546221
[TBL] [Abstract][Full Text] [Related]
39. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach.
Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS
J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291
[TBL] [Abstract][Full Text] [Related]
40. Neurolymphomatosis: MRI and (18) FDG-PET features.
Lim AT; Clucas D; Khoo C; Parameswaran BK; Lau E
J Med Imaging Radiat Oncol; 2016 Feb; 60(1):92-5. PubMed ID: 25974748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
